Redwood Trust's CFO, Carillo Brooke, increased her stake by purchasing 26,065 shares, showing confidence despite a major shareholder urging the board to consider selling the company. The stock trades at a 33% discount to its GAAP book value due to risks from legacy assets, although its core mortgage banking operations remain strong with a 33% annualized return on capital. The insider buying signals optimism about the company's future, while the shareholder's call for a sale suggests strategic uncertainty. Analysts maintain a Buy rating with a $5.52 price target, highlighting potential upside if legacy issues are resolved.
Redwood Trust's CFO increasing her stake provides context for this snapshot of the Financials sector on Pluang. For readers following Financials, here is Pluang's market snapshot as of Sep 16, 2026 01:02 WIB: Of 74 priced Financials-sector US stocks tradable on Pluang, 13 rose and 59 fell today. Notable prices include OXLC at USD 9.36 with a 1-day change of -1.89%, BNY at USD 155.00 with a 1-day change of -1.69%, and NMR at USD 10.55 with a 1-day change of -1.63%.
Obra Capital has closed its fifth Collateralized Loan Obligation (CLO) offering, raising $403.6 million. This deal brings the firm's total CLO issuance to more than $2 billion across five deals in less than two years, demonstrating strong investor co...
ImPact Biotech reported positive early results from its Phase 1 trial of Padeliporfin VTP in patients with locally advanced, unresectable pancreatic cancer. Of 12 patients treated, 75% have undergone or are scheduled for surgery, with over half achie...
Avacta Therapeutics presented positive preclinical and early clinical data for AVA6103, a novel peptide-drug conjugate targeting FAP-positive tumors resistant to Enhertu. AVA6103 demonstrated superior tumor control and prolonged drug release in precl...
eSoftware Associates has introduced a free five-minute AI readiness assessment to help regulated organizations identify and prioritize security risks related to sensitive file access in Microsoft 365 before deploying Copilot. The assessment highlight...
Balchem Corporation reported strong Q3 2026 results with net sales of $290.7 million, up 8.6% year-over-year, and net earnings of $46.7 million, a 16% increase. Growth was driven by all three segments: Human Nutrition and Health, Animal Nutrition and...
